Tegaserod-d11, CAS 1134188-56-9

Product Description: Tegaserod-d11 is deuterated labeled Tegaserod (HY-14153). Tegaserod is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation. Tegaserod has anti-tumor activity and has the potential for irritable bowel syndrome (IBS) research[1][2][3].

Applications: Metabolism-protein/nucleotide metabolism

Formula: C16H12D11N5O

References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216./[2]Wei Liu, et al. Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications. J Exp Clin Cancer Res. 2020 Feb 21;39(1):38./[3]M D Crowell, et al. The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus. Neurogastroenterol Motil. 2005 Oct;17(5):738-43./[4]D T Beattie, et al. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol. 2004 Nov;143(5):549-60.

CAS Number: 1134188-56-9

Molecular Weight: 312.45

Research Area: Cancer; Metabolic Disease

Solubility: 10 mM in DMSO

Target: 5-HT Receptor;Apoptosis;Isotope-Labeled Compounds

• Artikelnummer: MEXHY-14153S-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-14153S-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK